Literature DB >> 24821865

Delays in the submission of new drugs in Canada.

Ali Shajarizadeh1, Aidan Hollis2.   

Abstract

Mesh：

Year:  2014        PMID： 24821865      PMCID： PMC4284192          DOI： 10.1503/cmaj.130814

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Orphan drug development is not taking off.

Authors:  Roberta Joppi; Vittorio Bertele; Silvio Garattini
Journal:  Br J Clin Pharmacol       Date:  2009-01-21       Impact factor: 4.335

2.  Incentives for orphan drug research and development in the United States.

Authors:  Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Sheryl L Szeinbach; Jay Visaria
Journal:  Orphanet J Rare Dis       Date:  2008-12-16       Impact factor: 4.123
  2 in total
  5 in total

1.  Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.

Authors:  Christine Troskie; Judith A Soon; Arianne Y Albert; Wendy V Norman
Journal:  CMAJ Open       Date:  2016-11-03

2.  Pediatric drug data in Canadian drug monographs: a descriptive analysis.

Authors:  Preeya Raja; Mark Duffett; Maryann Mazer-Amirshahi; Ashaka Patel; Andrea Gilpin; Catherine Litalien; Anthony K Chan; John van den Anker; Thierry Lacaze-Masmonteil; Samira Samiee-Zafarghandy
Journal:  CMAJ Open       Date:  2020-08-31

3.  Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.

Authors:  Kevin Outterson; Ebiowei S F Orubu; John Rex; Christine Årdal; Muhammad H Zaman
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 20.999

4.  Health Canada's use of its priority review process for new drugs: a cohort study.

Authors:  Joel Lexchin
Journal:  BMJ Open       Date:  2015-05-11       Impact factor: 2.692

5.  Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997-2012.

Authors:  Matthew Herder; Timothy Mark Krahn
Journal:  Healthc Policy       Date:  2016-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.